Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Rossi

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
RNA (New York, N.Y.)|October 31, 2022
Human PRPF39 is an alternative splicing factor recruiting U1 snRNP to weak 5' splice sitesSara Espinosa, Francesca De Bortoli, Xueni Li, et al.
Chemmedchem|June 11, 2024
Rational Design of Novel Allosteric EYA2 Inhibitors as Potential Therapeutics for Multiple Brain CancersLukas Gardner, John Rossi, Brock Armstrong, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2007
Safety and efficacy of a lentiviral vector containing three anti-HIV genes--CCR5 ribozyme, tat-rev siRNA, and TAR decoy--in SCID-hu mouse-derived T cellsJoseph Anderson, Ming-Jie Li, Brent Palmer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 10, 2017
Safety and Efficacy of a Lentiviral Vector Containing Three Anti-HIV Genes-CCR5 Ribozyme, Tat-rev siRNA, and TAR Decoy-in SCID-hu Mouse-Derived T CellsJoseph Anderson, Ming-Jie Li, Brent Palmer, et al.
American Journal of Physiology. Renal Physiology|October 10, 2002
Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cellsMarpadga A Reddy, Sharon G Adler, Young-Sook Kim, et al.
Plos One|July 2, 2009
Evidence for X-chromosomal schizophrenia associated with microRNA alterationsJinong Feng, Guihua Sun, Jin Yan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2016
A Phase I, First-in-Human Study of AMG 780, an Angiopoietin-1 and -2 Inhibitor, in Patients with Advanced Solid TumorsAfshin Dowlati, Gordana Vlahovic, Ronald B Natale, et al.
Scientific Reports|December 9, 2015
A Novel Class of HIV-1 Antiviral Agents Targeting HIV via a SUMOylation-Dependent MechanismIkenna G Madu, Shirley Li, Baozong Li, et al.
Molecular Therapy. Nucleic Acids|March 5, 2026
GalNAc-conjugated siRNA targeting C/EBPβ reverses metabolic dysfunction and restores liver homeostasis in a murine MASLD modelShirin Elizabeth Khorsandi, Daniel Vasconcelos, Roman Nicholas, et al.
Proteomics|July 2, 2003
Analysis of rat testicular protein expression following 91-day exposure to JP-8 jet fuel vaporFrank A Witzmann, Andrew Bobb, G Bruce Briggs, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
RNA (New York, N.Y.)|October 31, 2022
Human PRPF39 is an alternative splicing factor recruiting U1 snRNP to weak 5' splice sitesSara Espinosa, Francesca De Bortoli, Xueni Li, et al.
Chemmedchem|June 11, 2024
Rational Design of Novel Allosteric EYA2 Inhibitors as Potential Therapeutics for Multiple Brain CancersLukas Gardner, John Rossi, Brock Armstrong, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2007
Safety and efficacy of a lentiviral vector containing three anti-HIV genes--CCR5 ribozyme, tat-rev siRNA, and TAR decoy--in SCID-hu mouse-derived T cellsJoseph Anderson, Ming-Jie Li, Brent Palmer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 10, 2017
Safety and Efficacy of a Lentiviral Vector Containing Three Anti-HIV Genes-CCR5 Ribozyme, Tat-rev siRNA, and TAR Decoy-in SCID-hu Mouse-Derived T CellsJoseph Anderson, Ming-Jie Li, Brent Palmer, et al.
American Journal of Physiology. Renal Physiology|October 10, 2002
Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cellsMarpadga A Reddy, Sharon G Adler, Young-Sook Kim, et al.
Plos One|July 2, 2009
Evidence for X-chromosomal schizophrenia associated with microRNA alterationsJinong Feng, Guihua Sun, Jin Yan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2016
A Phase I, First-in-Human Study of AMG 780, an Angiopoietin-1 and -2 Inhibitor, in Patients with Advanced Solid TumorsAfshin Dowlati, Gordana Vlahovic, Ronald B Natale, et al.
Scientific Reports|December 9, 2015
A Novel Class of HIV-1 Antiviral Agents Targeting HIV via a SUMOylation-Dependent MechanismIkenna G Madu, Shirley Li, Baozong Li, et al.
Molecular Therapy. Nucleic Acids|March 5, 2026
GalNAc-conjugated siRNA targeting C/EBPβ reverses metabolic dysfunction and restores liver homeostasis in a murine MASLD modelShirin Elizabeth Khorsandi, Daniel Vasconcelos, Roman Nicholas, et al.
Proteomics|July 2, 2003
Analysis of rat testicular protein expression following 91-day exposure to JP-8 jet fuel vaporFrank A Witzmann, Andrew Bobb, G Bruce Briggs, et al.
Pageof 9